Review of the 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: What is New and Why?

Abstract In September 2014, the 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes (NSTE-ACS) was released electronically; it was published in print 3 months later, in December 2014. The management of NSTE-ACS has evolved significantly in recent years, and a number of novel agents are now available for use (e.g., prasugrel, ticagrelor). In addition, several key diagnostic and therapeutic agents that were formerly considered hallmarks in the treatment of acute coronary syndrome have fallen out of favor (e.g., glycoprotein inhibitors, CK-MB). The 2014 AHA/ACC NSTE-ACS guideline document is the first comprehensive publication for the treatment of non-ST-elevation acute coronary syndromes since 2007; this review paper serves as an overview of the 2014 NSTE-ACS guideline, with emphasis on several paramount changes since the 2007 version.
Source: Current Cardiovascular Risk Reports - Category: Cardiology Source Type: research